Retagliptin phosphate Catalog No.:M19044-C Glut1 deficiency syndrome and erythrocyte

Glut1 deficiency syndrome and erythrocyte glucose uptake assay

Nepafenac delays the progression of malignancy as well as reduces weight in an ocular and metastatic animal model of uveal melanoma

1983 Apr 21

Chemical Name: L-aspartyl-L-leucyl-L-prolyl-L-leucyl-L-threonyl-L-phenylalanylglycylglycylglycyl-L-threonyl-L-lysine--2

ClH/c1-31-10-17(13-2-3-16(22)15(8-13)21(23

Retagliptin phosphate Catalog No.:M19044-C Glut1 deficiency syndrome and erythrocyteRetagliptin phosphate (SP2086 phosphate) is a selective, competitive and orally active dipeptidyl peptidase 4 (DPP 4) inhibitor. Retagliptin phosphate can be used for type 2 diabetes mellitus (T2DM) research. Product information CAS Number: 1256756 88 3 Molecular Weight: 562. 36 Formula: C19H21F6N4O7P Chemical Name: methyl 7 [(3R) 3 amino 4 (2,4,5 trifluorophenyl)butanoyl] 3 (trifluoromethyl) 5H,6H,7H,8H imidazo[1,5 a]pyrazine 1 carboxylate;